san007
Botanicalexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 21, 2017 (NCT02871479)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- san007
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03000595 | Phase 2 | May 1, 2017 | ClinDatrix, Inc., Fremantle Dermatology, Santalis Pharmaceuticals |
| NCT02871479 | Phase 2 | Apr 21, 2017 | Santalis Pharmaceuticals, Texas Dermatology and Laser Specialists |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Santalis Pharmaceuticals | For profit | 2 | 2 | 1 | 2017 |
| ClinDatrix, Inc. | For profit | 1 | 0 | 1 | 2017 |
| Fremantle Dermatology | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Texas Dermatology and Laser Specialists | Academic/Hospital | 1 | 0 | 1 | 2017 |
4 organizations
Page 1 / 1